Accepted for/Published in: JMIR mHealth and uHealth
Date Submitted: Aug 2, 2019
Open Peer Review Period: Aug 6, 2019 - Oct 1, 2019
Date Accepted: Mar 1, 2020
(closed for review but you can still tweet)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Facilitating Management of Opioid Use Disorder: A Technology Landscape Analysis
ABSTRACT
Background:
Advances in technology engender investigation of technology solutions to Opioid Use Disorder (OUD). However, in comparison to chronic disease management, the application of mobile health (mHealth) to OUD has been limited.
Objective:
The objectives of this paper are to (1) document the currently available opioid-related mHealth applications (apps) and (2) review past and existing technology solutions that address OUD.
Methods:
We used a two-phase parallel search approach: (1) app search to determine availability of opioid-related mHealth apps, and (2) focused review of literature to identify relevant technologies and mHealth apps used to address OUD.
Results:
The app search revealed a steady rise in app development, with the majority of apps being clinician-facing. A majority of the apps were designed to aid in opioid dose conversion. Despite the availability of these apps, the focused review found no study that investigated the efficacy of mHealth apps to address OUD.
Conclusions:
Our findings highlight a general gap in technological solutions of OUD management, and the potential for mHealth apps and wearable sensors to address OUD.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.